Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Halloran

Showing results (251-260 of 265) with videos related to

Pageof 27
Sort By:
Transplantation|December 27, 1996
A randomized, prospective multicenter pharmacoepidemiologic study of cyclosporine microemulsion in stable renal graft recipients. Report of the Canadian Neoral Renal Transplantation Study GroupP Keown, D Landsberg, P Halloran, et al.
Alimentary Pharmacology & Therapeutics|March 3, 2017
Clinical, endoscopic and radiographic outcomes with ustekinumab in medically-refractory Crohn's disease: real world experience from a multicentre cohortC Ma, R N Fedorak, G G Kaplan, et al.
Gut|December 13, 2018
Faecal immunochemical tests (FIT) versus colonoscopy for surveillance after screening and polypectomy: a diagnostic accuracy and cost-effectiveness studyAmanda J Cross, Kate Wooldrage, Emma C Robbins, et al.
Inflammatory Bowel Diseases|March 23, 2017
Long-term Maintenance of Clinical, Endoscopic, and Radiographic Response to Ustekinumab in Moderate-to-Severe Crohn's Disease: Real-world Experience from a Multicenter Cohort StudyChristopher Ma, Richard N Fedorak, Gilaad G Kaplan, et al.
Transplantation|February 7, 2001
Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantationC Johnson, N Ahsan, T Gonwa, et al.
Therapeutic Advances in Gastroenterology|October 3, 2022
A randomized controlled trial of a multicomponent online stress reduction intervention in inflammatory bowel diseaseFarhad Peerani, Makayla Watt, Kathleen P Ismond, et al.
Transplantation|March 21, 1998
Safety and tolerability of cyclosporine and cyclosporine microemulsion during 18 months of follow-up in stable renal transplant recipients: a report of the Canadian Neoral Renal Study GroupE Cole, P Keown, D Landsberg, et al.
Journal of the Canadian Association of Gastroenterology|July 12, 2019
Preoperative Ustekinumab Treatment Is Not Associated With Increased Postoperative Complications in Crohn's Disease: A Canadian Multi-Centre Observational Cohort StudyHang Hock Shim, Christopher Ma, Paulo G Kotze, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|June 23, 2023
Reproducibility in modeling and simulation of the knee: Academic, industry, and regulatory perspectivesCarl W Imhauser, Andrew P Baumann, Xiangyi Cheryl Liu, et al.
Gastroenterology Research and Practice|April 13, 2016
Reducing the Social Gradient in Uptake of the NHS Colorectal Cancer Screening Programme Using a Narrative-Based Information Leaflet: A Cluster-Randomised TrialLesley M McGregor, Christian von Wagner, Wendy Atkin, et al.
Pageof 27

Showing results (251-260 of 265) with videos related to

Sort By:
Pageof 27
Transplantation|December 27, 1996
A randomized, prospective multicenter pharmacoepidemiologic study of cyclosporine microemulsion in stable renal graft recipients. Report of the Canadian Neoral Renal Transplantation Study GroupP Keown, D Landsberg, P Halloran, et al.
Alimentary Pharmacology & Therapeutics|March 3, 2017
Clinical, endoscopic and radiographic outcomes with ustekinumab in medically-refractory Crohn's disease: real world experience from a multicentre cohortC Ma, R N Fedorak, G G Kaplan, et al.
Gut|December 13, 2018
Faecal immunochemical tests (FIT) versus colonoscopy for surveillance after screening and polypectomy: a diagnostic accuracy and cost-effectiveness studyAmanda J Cross, Kate Wooldrage, Emma C Robbins, et al.
Inflammatory Bowel Diseases|March 23, 2017
Long-term Maintenance of Clinical, Endoscopic, and Radiographic Response to Ustekinumab in Moderate-to-Severe Crohn's Disease: Real-world Experience from a Multicenter Cohort StudyChristopher Ma, Richard N Fedorak, Gilaad G Kaplan, et al.
Transplantation|February 7, 2001
Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantationC Johnson, N Ahsan, T Gonwa, et al.
Therapeutic Advances in Gastroenterology|October 3, 2022
A randomized controlled trial of a multicomponent online stress reduction intervention in inflammatory bowel diseaseFarhad Peerani, Makayla Watt, Kathleen P Ismond, et al.
Transplantation|March 21, 1998
Safety and tolerability of cyclosporine and cyclosporine microemulsion during 18 months of follow-up in stable renal transplant recipients: a report of the Canadian Neoral Renal Study GroupE Cole, P Keown, D Landsberg, et al.
Journal of the Canadian Association of Gastroenterology|July 12, 2019
Preoperative Ustekinumab Treatment Is Not Associated With Increased Postoperative Complications in Crohn's Disease: A Canadian Multi-Centre Observational Cohort StudyHang Hock Shim, Christopher Ma, Paulo G Kotze, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|June 23, 2023
Reproducibility in modeling and simulation of the knee: Academic, industry, and regulatory perspectivesCarl W Imhauser, Andrew P Baumann, Xiangyi Cheryl Liu, et al.
Gastroenterology Research and Practice|April 13, 2016
Reducing the Social Gradient in Uptake of the NHS Colorectal Cancer Screening Programme Using a Narrative-Based Information Leaflet: A Cluster-Randomised TrialLesley M McGregor, Christian von Wagner, Wendy Atkin, et al.
Pageof 27